Inventor · disambiguated record
Matthias Wabl
Also filed as: WABL MATTHIAS
14 granted patents·21 pending applications·164 citations·filing 1996–2024
90Inventor score
Top patents by PatentIndex Score
35 records- 0188US7459280B2Methods for diagnosing and treating kidney cancerPICOBELLA LLC·Filed 2006·Granted Dec 2, 2008·16 cites·8 claims
- 0288US5885827AEukaryotic high rate mutagenesis systemUNIVERSTIY OF CALIFORNIA·Filed 1996·Granted Mar 23, 1999·121 cites·33 claims
- 0385US7488584B2Methods for diagnosing and treating kidney and colorectal cancerPICOBELLA·Filed 2006·Granted Feb 10, 2009·14 cites·10 claims
- 0483US10793829B2Transgenic mammals and methods of use thereofTRIANNI INC·Filed 2017·Granted Oct 6, 2020·3 cites·13 claims
- 0578US2024156071A1Enhanced immunoglobulin diversityTRIANNI INC·Filed 2023·Application pending·0 cites
- 0676US10662256B2Transgenic mammals and methods of use thereofTRIANNI INC·Filed 2017·Granted May 26, 2020·1 cites·13 claims
- 0771US2023010106A1Single chain vh and heavy chain antibodiesTRIANNI INC·Filed 2022·Application pending·0 cites
- 0868US2024175049A1Long germline dh genes and long hcdr3 antibodiesTRIANNI INC·Filed 2024·Application pending·0 cites
- 0967US11889821B2Enhanced immunoglobulin diversityTRIANNI INC·Filed 2020·Granted Feb 6, 2024·0 cites·12 claims
- 1067US10881084B2Transgenic animals and methods of useWABL MATTHIAS·Filed 2011·Granted Jan 5, 2021·3 cites·7 claims
- 1166US12096753B2Transgenic animals and methods of useTRIANNI INC·Filed 2020·Granted Sep 24, 2024·0 cites·11 claims
- 1264US8071324B2Methods for diagnosing and treating kidney cancerWANG BRUCE·Filed 2008·Granted Dec 6, 2011·0 cites·3 claims
- 1363US12049516B2Transgenic mammals and methods of use thereofTRIANNI INC·Filed 2020·Granted Jul 30, 2024·0 cites·5 claims
- 1462US2020190218A1Enhanced production of immunoglobulinsTRIANNI INC·Filed 2020·Application pending·0 cites
- 1559US7723043B2Methods for screening for prostate cancerPICOBELLA LP·Filed 2006·Granted May 25, 2010·1 cites·4 claims
- 1659US2024423175A1Transgenic mammals and methods of use thereofTRIANNI INC·Filed 2022·Application pending·0 cites
- 1758US11414478B2Single chain VH and heavy chain antibodiesTRIANNI INC·Filed 2018·Granted Aug 16, 2022·0 cites·6 claims
- 1856US2024215556A1Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereofTRIANNI INC·Filed 2022·Application pending·0 cites
- 1955US2024023526A1Heavy chain-only antibodiesTRIANNI INC·Filed 2021·Application pending·0 cites
- 2054US11946063B2Long germline DH genes and long HCDR3 antibodiesTRIANNI INC·Filed 2018·Granted Apr 2, 2024·0 cites·7 claims
- 2154US2017058052A1Enhanced production of immunoglobulinsTRIANNI INC·Filed 2016·Application pending·0 cites
- 2253US2018230238A1Enhanced production of immunoglobulinsTRIANNI INC·Filed 2016·Application pending·0 cites
- 2351US2010041126A1Methods for diagnosing and treating prostate cancerWANG BRUCE·Filed 2009·Application pending·0 cites
- 2450US2009258358A1Methods for Diagnosing and Treating Kidney and Colorectal CancerWANG BRUCE·Filed 2009·Application pending·0 cites
- 2550US2003143611A1Polynucleotides encoding proteins mediating switch recombinationFiled 2003·Application pending·0 cites
- 2647US2009220501A1Anti-CD19 Antibody, Immunotoxin and Treatment MethodFEY GEORG H·Filed 2008·Application pending·0 cites
- 2746US6528284B1Polynucleotides encoding proteins mediating switch recombinationHOFFMANN LA ROCHE·Filed 1998·Granted Mar 4, 2003·5 cites·11 claims
- 2846US2021000087A1Transgenic mammals and methods of use thereofTRIANNI INC·Filed 2020·Application pending·0 cites
- 2946US2008234213A1Oncogenic regulatory RNAs for diagnostics and therapeuticsWABL MATTHIAS·Filed 2006·Application pending·0 cites
- 3043US2021059229A1Adam6 knockin miceTRIANNI INC·Filed 2020·Application pending·0 cites
- 3143US2003119190A1Genetic tagging strategy for inducing and identifying mutations in a genomic sequenceFiled 2002·Application pending·0 cites
- 3242US2022369609A1Transgenic mammals and methods of use thereofTRIANNI INC·Filed 2020·Application pending·0 cites
- 3342US2020031943A1Type 1 interferon receptor antagonists for use in methods of treating tuberculosis and other infectious diseasesAUSTRIANNI GMBH·Filed 2018·Application pending·0 cites
- 3441US2013224209A1Methods for diagnosing and treating prostate and lung cancerPICOBELLA LLC·Filed 2013·Application pending·0 cites
- 3536US2003166018A1Methods for identifying agents that modulate mast cell degranulationFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →